Real time analysis of binding between Rituximab (anti-CD20 antibody) and B lymphoma cells.
Real time analysis of binding between Rituximab (anti-CD20 antibody) and B lymphoma cells.
复制标题
DOI：
10.1021/ac400062v
复制
发表时间：
2013-09-17
影响因子：
7.4
通讯作者：
Zeng, Xiangqun
中科院分区：
文献类型：
--
作者：
Tan, Liang;Lin, Peiling;Chisti, Mohammad M.;Rehman, Abdul;Zeng, Xiangqun
CD20, expressed on greater than 90% of B-lymphocytic lymphomas, is an attractive target for antibody therapy. Rituximab is a chimeric murine/human-engineered monoclonal antibody and can selectively deplete CD20-expressing cells in peripheral blood and lymphoid tissues. The immobilization of B-lymphoblast-like Burkitt's lymphoma Raji cells on the quartz crystal microbalance (QCM) gold electrode surface using RGD tripeptide was electrochemically confirmed. The real-time processes of attachment of Raji cells on the gold electrode and the subsequent binding of Rituximab to the cells were studied using QCM biosensor. The interaction between Rituximab and Raji cells led to the increased resonant frequency shifts (Δf0) in the studied antibody concentration range from 5 to 250 µg mL−1 following the Langmuir adsorption model. From these observations, the apparent binding constant between a single-layer of Rituximab and Raji cells was calculated to be 1.6×106 M−1. Control experiments using other therapeutic antibodies (i.e., Trastuzumab and Bevacizumab) and different cells (i.e., T cells and endothelial cells) proved the specific interaction between Rituximab and B cells. The effects of Ca2+ and Mn2+ ions on the Rituximab-Raji cell interaction were also studied providing the enhanced QCM signals, in particular, further indicating that CD20 is a calcium ion channel that can transport these metal ions into the cells and accelerate the cell lysis induced by Rituximab. Thus the real time capability of QCM and its simplicity of operation are highly suitable for multipurpose studies on living cells including cell-immobilization, cytotoxicity of drugs, and the cell action mechanisms.
登录
查看更多内容
影响因子：
3.4
作者：
Leget, Gail A.;Czuczman, Myron S.
通讯作者：
Czuczman, Myron S.
影响因子：
3.2
作者：
GRANSTAFF, VE;MARTIN, SJ
通讯作者：
MARTIN, SJ
影响因子：
158.5
作者：
Edwards, JCW;Szczepanski, L;Shaw, T
通讯作者：
Shaw, T
金纳米颗粒-壳聚糖纳米复合凝胶的仿生载体，用于 K562 白血病细胞的固定化和电化学研究
影响因子：
6.2
作者：
Ding, Lin;Hao, Chen;Ju, Huangxian
通讯作者：
Ju, Huangxian
影响因子：
2.7
作者：
Bjorkelund, Hanna;Gedda, Lars;Andersson, Karl
通讯作者：
Andersson, Karl